These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

344 related articles for article (PubMed ID: 30901713)

  • 1. Quantification of white matter cellularity and damage in preclinical and early symptomatic Alzheimer's disease.
    Wang Q; Wang Y; Liu J; Sutphen CL; Cruchaga C; Blazey T; Gordon BA; Su Y; Chen C; Shimony JS; Ances BM; Cairns NJ; Fagan AM; Morris JC; Benzinger TLS
    Neuroimage Clin; 2019; 22():101767. PubMed ID: 30901713
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Investigating White Matter Neuroinflammation in Alzheimer Disease Using Diffusion-Based Neuroinflammation Imaging.
    Wang Q; Schindler SE; Chen G; Mckay NS; McCullough A; Flores S; Liu J; Sun Z; Wang S; Wang W; Hassenstab J; Cruchaga C; Perrin RJ; Fagan AM; Morris JC; Wang Y; Benzinger TLS
    Neurology; 2024 Feb; 102(4):e208013. PubMed ID: 38315956
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CSF β-amyloid and white matter damage: a new perspective on Alzheimer's disease.
    Pietroboni AM; Scarioni M; Carandini T; Basilico P; Cadioli M; Giulietti G; Arighi A; Caprioli M; Serra L; Sina C; Fenoglio C; Ghezzi L; Fumagalli GG; De Riz MA; Calvi A; Triulzi F; Bozzali M; Scarpini E; Galimberti D
    J Neurol Neurosurg Psychiatry; 2018 Apr; 89(4):352-357. PubMed ID: 29054920
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Associations between white matter microstructure and amyloid burden in preclinical Alzheimer's disease: A multimodal imaging investigation.
    Racine AM; Adluru N; Alexander AL; Christian BT; Okonkwo OC; Oh J; Cleary CA; Birdsill A; Hillmer AT; Murali D; Barnhart TE; Gallagher CL; Carlsson CM; Rowley HA; Dowling NM; Asthana S; Sager MA; Bendlin BB; Johnson SC
    Neuroimage Clin; 2014; 4():604-14. PubMed ID: 24936411
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cerebrospinal Fluid Markers of Alzheimer's Disease Pathology and Microglial Activation are Associated with Altered White Matter Microstructure in Asymptomatic Adults at Risk for Alzheimer's Disease.
    Melah KE; Lu SY; Hoscheidt SM; Alexander AL; Adluru N; Destiche DJ; Carlsson CM; Zetterberg H; Blennow K; Okonkwo OC; Gleason CE; Dowling NM; Bratzke LC; Rowley HA; Sager MA; Asthana S; Johnson SC; Bendlin BB
    J Alzheimers Dis; 2016; 50(3):873-86. PubMed ID: 26836182
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cerebrospinal fluid biomarkers of neurofibrillary tangles and synaptic dysfunction are associated with longitudinal decline in white matter connectivity: A multi-resolution graph analysis.
    Kim WH; Racine AM; Adluru N; Hwang SJ; Blennow K; Zetterberg H; Carlsson CM; Asthana S; Koscik RL; Johnson SC; Bendlin BB; Singh V
    Neuroimage Clin; 2019; 21():101586. PubMed ID: 30502079
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Distinct White Matter Changes Associated with Cerebrospinal Fluid Amyloid-β1-42 and Hypertension.
    Al-Janabi OM; Brown CA; Bahrani AA; Abner EL; Barber JM; Gold BT; Goldstein LB; Murphy RR; Nelson PT; Johnson NF; Shaw LM; Smith CD; Trojanowski JQ; Wilcock DM; Jicha GA
    J Alzheimers Dis; 2018; 66(3):1095-1104. PubMed ID: 30400099
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Longitudinal structural cerebral changes related to core CSF biomarkers in preclinical Alzheimer's disease: A study of two independent datasets.
    Falcon C; Tucholka A; Monté-Rubio GC; Cacciaglia R; Operto G; Rami L; Gispert JD; Molinuevo JL;
    Neuroimage Clin; 2018; 19():190-201. PubMed ID: 30023169
    [TBL] [Abstract][Full Text] [Related]  

  • 9. White matter integrity is associated with cerebrospinal fluid markers of Alzheimer's disease in normal adults.
    Gold BT; Zhu Z; Brown CA; Andersen AH; LaDu MJ; Tai L; Jicha GA; Kryscio RJ; Estus S; Nelson PT; Scheff SW; Abner E; Schmitt FA; Van Eldik LJ; Smith CD
    Neurobiol Aging; 2014 Oct; 35(10):2263-71. PubMed ID: 24866404
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The association between biomarkers in cerebrospinal fluid and structural changes in the brain in patients with Alzheimer's disease.
    Li X; Li TQ; Andreasen N; Wiberg MK; Westman E; Wahlund LO
    J Intern Med; 2014 Apr; 275(4):418-27. PubMed ID: 24237038
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cerebrospinal Fluid 7-Ketocholesterol Level is Associated with Amyloid-β42 and White Matter Microstructure in Cognitively Healthy Adults.
    Iriondo A; García-Sebastian M; Arrospide A; Arriba M; Aurtenetxe S; Barandiaran M; Clerigue M; Ecay-Torres M; Estanga A; Gabilondo A; Izagirre A; Saldias J; Tainta M; Villanua J; Blennow K; Zetterberg H; Mar J; Abad-García B; Dias IHK; Goñi FM; Martínez-Lage P
    J Alzheimers Dis; 2020; 76(2):643-656. PubMed ID: 32538843
    [TBL] [Abstract][Full Text] [Related]  

  • 12. White matter changes in preclinical Alzheimer's disease: a magnetic resonance imaging-diffusion tensor imaging study on cognitively normal older people with positive amyloid β protein 42 levels.
    Molinuevo JL; Ripolles P; Simó M; Lladó A; Olives J; Balasa M; Antonell A; Rodriguez-Fornells A; Rami L
    Neurobiol Aging; 2014 Dec; 35(12):2671-2680. PubMed ID: 25002037
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cognition-related white matter integrity dysfunction in Alzheimer's disease with diffusion tensor image.
    Li Y; Feng F; Lin P; Huang ZG; Liu T; Zhou B; Yao H; Zheng L; Li C; Wang P; Zhang Z; Guo Y; Wang L; An N; Zhu X; Zhang X; Wang J
    Brain Res Bull; 2018 Oct; 143():207-216. PubMed ID: 30240840
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relationships Between Diffusion Tensor Imaging and Cerebrospinal Fluid Metrics in Early Stages of the Alzheimer's Disease Continuum.
    Alm KH; Bakker A
    J Alzheimers Dis; 2019; 70(4):965-981. PubMed ID: 31306117
    [TBL] [Abstract][Full Text] [Related]  

  • 15. White Matter Abnormalities Track Disease Progression in PSEN1 Autosomal Dominant Alzheimer's Disease.
    Sánchez-Valle R; Monté GC; Sala-Llonch R; Bosch B; Fortea J; Lladó A; Antonell A; Balasa M; Bargalló N; Molinuevo JL
    J Alzheimers Dis; 2016; 51(3):827-35. PubMed ID: 26923015
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of Amyloid Pathology With Myelin Alteration in Preclinical Alzheimer Disease.
    Dean DC; Hurley SA; Kecskemeti SR; O'Grady JP; Canda C; Davenport-Sis NJ; Carlsson CM; Zetterberg H; Blennow K; Asthana S; Sager MA; Johnson SC; Alexander AL; Bendlin BB
    JAMA Neurol; 2017 Jan; 74(1):41-49. PubMed ID: 27842175
    [TBL] [Abstract][Full Text] [Related]  

  • 17.
    Moscoso A; Silva-Rodríguez J; Aldrey JM; Cortés J; Pías-Peleteiro JM; Ruibal Á; Aguiar P;
    Eur J Nucl Med Mol Imaging; 2022 Mar; 49(4):1242-1253. PubMed ID: 34581847
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Loss of white matter integrity reflects tau accumulation in Alzheimer disease defined regions.
    Strain JF; Smith RX; Beaumont H; Roe CM; Gordon BA; Mishra S; Adeyemo B; Christensen JJ; Su Y; Morris JC; Benzinger TLS; Ances BM
    Neurology; 2018 Jul; 91(4):e313-e318. PubMed ID: 29959265
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regionally specific changes in the hippocampal circuitry accompany progression of cerebrospinal fluid biomarkers in preclinical Alzheimer's disease.
    Tardif CL; Devenyi GA; Amaral RSC; Pelleieux S; Poirier J; Rosa-Neto P; Breitner J; Chakravarty MM;
    Hum Brain Mapp; 2018 Feb; 39(2):971-984. PubMed ID: 29164798
    [TBL] [Abstract][Full Text] [Related]  

  • 20. White matter hyperintensities and CSF Alzheimer disease biomarkers in preclinical Alzheimer disease.
    Soldan A; Pettigrew C; Zhu Y; Wang MC; Moghekar A; Gottesman RF; Singh B; Martinez O; Fletcher E; DeCarli C; Albert M;
    Neurology; 2020 Mar; 94(9):e950-e960. PubMed ID: 31888969
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.